|
1
|
Alberts SR, Cervantes A and van de Velde
CJ: Gastric cancer: epidemiology, pathology and treatment. Ann
Oncol. 14(Suppl 2): 31–36. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
3
|
Lu JB, Sun XB, Dai DX, et al: Epidemiology
of gastroenterologic cancer in Henan Province, China. World J
Gastroenterol. 9:2400–2403. 2003.PubMed/NCBI
|
|
4
|
Hyung WJ, Noh SH, Yoo CH, et al:
Prognostic significance of metastatic lymph node ratio in T3
gastric cancer. World J Surg. 26:323–329. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park JY, Park KH, Bang S, et al: CXCL5
overexpression is associated with late stage gastric cancer. J
Cancer Res Clin Oncol. 133:835–840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fidler IJ: Critical determinants of
metastasis. Semin Cancer Biol. 12:89–96. 2002. View Article : Google Scholar
|
|
7
|
Murphy PM, Baggiolini M, Charo IF, et al:
International union of pharmacology. XXII Nomenclature for
chemokine receptors. Pharmacol Rev. 52:145–176. 2000.PubMed/NCBI
|
|
8
|
Zlotnik A and Yoshie O: Chemokines: a new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rossi D and Zlotnik A: The biology of
chemokines and their receptors. Annu Rev Immunol. 18:217–243. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Muller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johrer K, Zelle-Rieser C, Perathoner A, et
al: Up-regulation of functional chemokine receptor CCR3 in human
renal cell carcinoma. Clin Cancer Res. 11:2459–2465. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Scotton CJ, Wilson JL, Milliken D, Stamp G
and Balkwill FR: Epithelial cancer cell migration: a role for
chemokine receptors? Cancer Res. 61:4961–4965. 2001.PubMed/NCBI
|
|
14
|
Schimanski CC, Schwald S, Simiantonaki N,
et al: Effect of chemokine receptors CXCR4 and CCR7 on the
metastatic behavior of human colorectal cancer. Clin Cancer Res.
11:1743–1750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Balkwill F: The significance of cancer
cell expression of the chemokine receptor CXCR4. Semin Cancer Biol.
14:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lazennec G and Richmond A: Chemokines and
chemokine receptors: new insights into cancer-related inflammation.
Trends Mol Med. 16:133–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Charo IF and Ransohoff RM: The many roles
of chemokines and chemokine receptors in inflammation. N Engl J
Med. 354:610–621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan MC, Goedegebuure PS, Belt BA, et al:
Disruption of CCR5-dependent homing of regulatory T cells inhibits
tumor growth in a murine model of pancreatic cancer. J Immunol.
182:1746–1755. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tanaka T, Bai Z, Srinoulprasert Y, Yang
BG, Hayasaka H and Miyasaka M: Chemokines in tumor progression and
metastasis. Cancer Sci. 96:317–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu JY, Deng XY, Bian XW, et al: The
expression of functional chemokine receptor CXCR4 is associated
with the metastatic potential of human nasopharyngeal carcinoma.
Clin Cancer Res. 11:4658–4665. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ginestier C, Liu S, Diebel ME, et al:
CXCR1 blockade selectively targets human breast cancer stem cells
in vitro and in xenografts. J Clin Invest. 120:485–497. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Singh S, Nannuru KC, Sadanandam A, Varney
ML and Singh RK: CXCR1 and CXCR2 enhances human melanoma
tumourigenesis, growth and invasion. Br J Cancer. 100:1638–1646.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eck M, Schmausser B, Scheller K, Brandlein
S and Muller-Hermelink HK: Pleiotropic effects of CXC chemokines in
gastric carcinoma: differences in CXCL8 and CXCL1 expression
between diffuse and intestinal types of gastric carcinoma. Clin Exp
Immunol. 134:508–515. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kitadai Y, Takahashi Y, Haruma K, et al:
Transfection of interleukin-8 increases angiogenesis and
tumorigenesis of human gastric carcinoma cells in nude mice. Br J
Cancer. 81:647–653. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin BR, Chang CC, Chen LR, et al:
Cysteine-rich 61 (CCN1) enhances chemotactic migration,
transendothelial cell migration, and intravasation by concomitantly
up-regulating chemokine receptor 1 and 2. Mol Cancer Res.
5:1111–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Croker AK, Goodale D, Chu J, et al: High
aldehyde dehydrogenase and expression of cancer stem cell markers
selects for breast cancer cells with enhanced malignant and
metastatic ability. J Cell Mol Med. 13:2236–2252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kitadai Y, Haruma K, Mukaida N, et al:
Regulation of disease-progression genes in human gastric carcinoma
cells by interleukin 8. Clin Cancer Res. 6:2735–2740.
2000.PubMed/NCBI
|
|
29
|
Ju DW, Wei PK, Lin HM, Sun DZ, Yu S and
Xiu LJ: Effects of Xiaotan Sanjie decoction on expressions of
interleukin-8 and its receptors in gastric tumor xenografts and
gastric tissue adjacent to the tumor in mice. Zhong Xi Yi Jie He
Xue Bao. 8:74–79. 2010.(In Chinese).
|
|
30
|
Wulfing P, Kersting C, Tio J, et al:
Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression
is correlated with vascular endothelial growth factor expression
and angiogenesis in breast cancer. Clin Cancer Res. 10:2393–2400.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miyazaki H, Patel V, Wang H, Edmunds RK,
Gutkind JS and Yeudall WA: Down-regulation of CXCL5 inhibits
squamous carcinogenesis. Cancer Res. 66:4279–4284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Richards BL, Eisma RJ, Spiro JD, Lindquist
RL and Kreutzer DL: Coexpression of interleukin-8 receptors in head
and neck squamous cell carcinoma. Am J Surg. 174:507–512. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kakinuma T and Hwang ST: Chemokines,
chemokine receptors, and cancer metastasis. J Leukoc Biol.
79:639–651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruffini PA, Morandi P, Cabioglu N,
Altundag K and Cristofanilli M: Manipulating the
chemokine-chemokine receptor network to treat cancer. Cancer.
109:2392–2404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Balakin KV, Ivanenkov YA, Tkachenko SE,
Kiselyov AS and Ivachtchenko AV: Regulators of chemokine receptor
activity as promising anticancer therapeutics. Curr Cancer Drug
Targets. 8:299–340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Koizumi K, Hojo S, Akashi T, Yasumoto K
and Saiki I: Chemokine receptors in cancer metastasis and cancer
cell-derived chemokines in host immune response. Cancer Sci.
98:1652–1658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang D, Sai J, Carter G, Sachpatzidis A,
Lolis E and Richmond A: PAK1 kinase is required for CXCL1-induced
chemotaxis. Biochemistry. 41:7100–7107. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schraufstatter IU, Chung J and Burger M:
IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac
signaling pathways. Am J Physiol Lung Cell Mol Physiol.
280:L1094–L1103. 2001.PubMed/NCBI
|
|
39
|
Venkatakrishnan G, Salgia R and Groopman
JE: Chemokine receptors CXCR-1/2 activate mitogen-activated protein
kinase via the epidermal growth factor receptor in ovarian cancer
cells. J Biol Chem. 275:6868–6875. 2000. View Article : Google Scholar
|
|
40
|
Bonacchi A, Romagnani P, Romanelli RG, et
al: Signal transduction by the chemokine receptor CXCR3: activation
of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls
cell migration and proliferation in human vascular pericytes. J
Biol Chem. 276:9945–9954. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chandrasekar B, Melby PC, Sarau HM, et al:
Chemokinecytokine cross-talk. The ELR+ CXC chemokine LIX
(CXCL5) amplifies a proinflammatory cytokine response via a
phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem.
278:4675–4686. 2003.PubMed/NCBI
|
|
42
|
Chandrasekar B, Bysani S and Mummidi S:
CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa
B kinase, and nuclear factor-kappa B and induces cell-cell adhesion
and aortic smooth muscle cell proliferation. J Biol Chem.
279:3188–3196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Caruso RA, Bellocco R, Pagano M, Bertoli
G, Rigoli L and Inferrera C: Prognostic value of intratumoral
neutrophils in advanced gastric carcinoma in a high-risk area in
northern Italy. Mod Pathol. 15:831–837. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Di Carlo E, Forni G, Lollini P, Colombo
MP, Modesti A and Musiani P: The intriguing role of
polymorphonuclear neutrophils in antitumor reactions. Blood.
97:339–345. 2001.PubMed/NCBI
|
|
45
|
Welch DR, Schissel DJ, Howrey RP and Aeed
PA: Tumor-elicited polymorphonuclear cells, in contrast to ‘normal’
circulating polymorphonuclear cells, stimulate invasive and
metastatic potentials of rat mammary adenocarcinoma cells. Proc
Natl Acad Sci USA. 86:5859–5863. 1989.PubMed/NCBI
|
|
46
|
De Larco JE, Wuertz BR and Furcht LT: The
potential role of neutrophils in promoting the metastatic phenotype
of tumors releasing interleukin-8. Clin Cancer Res. 10:4895–4900.
2004.PubMed/NCBI
|
|
47
|
Schmausser B, Josenhans C, Endrich S, et
al: Downregulation of CXCR1 and CXCR2 expression on human
neutrophils by Helicobacter pylori: a new pathomechanism in
H. pylori infection? Infect Immun. 72:6773–6779. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Backhed F, Torstensson E, Seguin D,
Richter-Dahlfors A and Rokbi B: Helicobacter pylori
infection induces interleukin-8 receptor expression in the human
gastric epithelium. Infect Immun. 71:3357–3360. 2003. View Article : Google Scholar
|
|
49
|
Gabellini C, Trisciuoglio D, Desideri M,
et al: Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on
human malignant melanoma progression. Eur J Cancer. 45:2618–2627.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Charafe-Jauffret E, Ginestier C, Iovino F,
et al: Breast cancer cell lines contain functional cancer stem
cells with metastatic capacity and a distinct molecular signature.
Cancer Res. 69:1302–1313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Folkman J: Angiogenesis and apoptosis.
Semin Cancer Biol. 13:159–167. 2003. View Article : Google Scholar
|
|
52
|
White ES, Flaherty KR, Carskadon S, et al:
Macrophage migration inhibitory factor and CXC chemokine expression
in non-small cell lung cancer: role in angiogenesis and prognosis.
Clin Cancer Res. 9:853–860. 2003.PubMed/NCBI
|
